Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8653345 | Annals of Vascular Surgery | 2018 | 18 Pages |
Abstract
Although the majority of patients with acute lower extremity DVT diagnosed in the outpatient vascular laboratory were not candidates for thrombolysis, one-third of those who may have benefited from CDT were referred to a vascular specialist to discuss lytic therapy. Given the potential benefits of CDT, it is imperative that patients with acute iliofemoral or extensive femoral DVT be offered an evaluation by a vascular specialist to optimize outcomes after this diagnosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mark Archie, Meena Archie, Jessica O'Connell, Brian G. DeRubertis,